Literature DB >> 16186082

Linkage with methadone treatment upon release from incarceration: a promising opportunity.

Josiah D Rich1, Michelle McKenzie, David C Shield, Francis A Wolf, R Garrett Key, Michael Poshkus, Jennifer Clarke.   

Abstract

Injection drug users (IDUs) are at increased risk for HIV, viral hepatitis, and tuberculosis, and making up more than a quarter of the incarcerated population in the United States. Methadone maintenance treatment of opiate addiction is highly effective at reducing drug use, drug-related criminal activity, and risk of HIV transmission. Recently released inmates are at particularly high risk for overdose and disease transmission. Linkage to methadone treatment immediately upon release from incarceration is a promising opportunity to combat disease transmission, facilitate reentry into the community, and reduce recidivism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16186082     DOI: 10.1300/J069v24n03_04

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  21 in total

1.  Incarceration and injection drug use in Baltimore, Maryland.

Authors:  Becky L Genberg; Jacquie Astemborski; David Vlahov; Gregory D Kirk; Shruti H Mehta
Journal:  Addiction       Date:  2015-05-07       Impact factor: 6.526

Review 2.  The HIV Care Cascade Before, During, and After Incarceration: A Systematic Review and Data Synthesis.

Authors:  Princess A Iroh; Helen Mayo; Ank E Nijhawan
Journal:  Am J Public Health       Date:  2015-05-14       Impact factor: 9.308

Review 3.  Hepatitis infection in the treatment of opioid dependence and abuse.

Authors:  Thomas F Kresina; Diana Sylvestre; Leonard Seeff; Alain H Litwin; Kenneth Hoffman; Robert Lubran; H Westley Clark
Journal:  Subst Abuse       Date:  2008-04-28

4.  A randomized trial of methadone initiation prior to release from incarceration.

Authors:  Michelle McKenzie; Nickolas Zaller; Samuel L Dickman; Traci C Green; Amisha Parihk; Peter D Friedmann; Josiah D Rich
Journal:  Subst Abus       Date:  2012       Impact factor: 3.716

5.  Interim methadone and patient navigation in jail: Rationale and design of a randomized clinical trial.

Authors:  Robert P Schwartz; Sharon M Kelly; Shannon G Mitchell; Laura Dunlap; Gary A Zarkin; Anjalee Sharma; Kevin E O'Grady; Jerome H Jaffe
Journal:  Contemp Clin Trials       Date:  2016-06-07       Impact factor: 2.226

6.  Risk factors for heroin use following release from jail or prison in adults in a Central Appalachian state between 2012-2017.

Authors:  Kirsten Elin Smith; Adrian Archuleta; Michele Staton; Erin Winston
Journal:  Am J Drug Alcohol Abuse       Date:  2020-04-03       Impact factor: 3.829

7.  Treating drug abuse and addiction in the criminal justice system: improving public health and safety.

Authors:  Redonna K Chandler; Bennett W Fletcher; Nora D Volkow
Journal:  JAMA       Date:  2009-01-14       Impact factor: 56.272

8.  A randomized clinical trial of methadone maintenance for prisoners: findings at 6 months post-release.

Authors:  Michael S Gordon; Timothy W Kinlock; Robert P Schwartz; Kevin E O'Grady
Journal:  Addiction       Date:  2008-08       Impact factor: 6.526

9.  The impact of the opioid crisis on U.S. state prison systems.

Authors:  Christy K Scott; Michael L Dennis; Christine E Grella; Allison F Mischel; John Carnevale
Journal:  Health Justice       Date:  2021-07-24

10.  Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey.

Authors:  Amy Nunn; Nickolas Zaller; Samuel Dickman; Catherine Trimbur; Ank Nijhawan; Josiah D Rich
Journal:  Drug Alcohol Depend       Date:  2009-07-21       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.